Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01
AstraZeneca
Aditya Bardia; Komal Jhaveri; Seock-Ah Im; Sonia Pernas; Michelino De Laurentiis; Shusen Wang; Noelia Martínez Jañez; Giuliano Borges; David W Cescon; Masaya Hattori; Yen-Shen Lu; Erika Hamilton; Qingyuan Zhang; Junji Tsurutani; Kevin Kalinsky; Pedro Emanuel Rubini Liedke; Lu Xu; Rick M Fairhurst; Sabrina Khan; Neelima Denduluri; Hope S Rugo; Binghe Xu; Barbara Pistilli; TROPION-Breast01 Investigators